Preliminary Injunction Against Boston Scientific Corporation's Guidezilla™ Catheter Vacated by Federal Circuit

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MINNEAPOLIS, April 15, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the preliminary injunction that was previously issued by the District Court for the District of Minnesota effective January 13, 2014 against Boston Scientific's Guidezilla guide extension catheter. In its one paragraph opinion vacating the injunction, the Court noted that a preliminary injunction is a "drastic and extraordinary remedy that is not to be routinely granted" and "at this stage of the case the record is too incomplete . . . to warrant the grant of a preliminary injunction."

Help employers find you! Check out all the jobs and post your resume.

Back to news